CRSP - CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)
2024-05-15 16:12:07 ET
CRISPR Therapeutics AG (CRSP)
BofA Securities 2024 Health Care Conference Call
May 15, 2024 12:20 PM ET
Company Participants
Samarth Kulkarni - Chief Executive Officer
Conference Call Participants
Geoffrey Meacham - Bank of America Merrill Lynch
Presentation
Geoffrey Meacham
All right. Here we go. Okay. Welcome to the second day of the Bank of America Health Care Conference. So my name is Geoff Meacham, I'm the senior biopharma analyst. We are thrilled today to have CRISPR Therapeutics. And speaking on behalf of CRISPR is CEO, Sam Kulkarni. And so Sam is going to give a talk, and then we'll do a little bit of Q&A afterwards. Sam?
Samarth Kulkarni
Thank you, Geoff, for having us here. It's always a pleasure to be at this conference, and great to see a lot of few familiar faces here. We thought with this year, instead of the full fireside chat, we'll do this presentation format and tell you about everything that's going on at CRISPR. It's been an incredibly busy year. We have – by the numbers, if you look at CRISPR, we have CASGEVY, which we're very proud of the approval of CASGEVY late last year together with our partners Vertex. And that's off to a great start in terms of a commercial launch....
CRISPR Therapeutics AG (CRSP) BofA Securities 2024 Health Care Conference (Transcript)